Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 2 4

Status

Completed 3Terminated 2

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 2Head & Neck 1Gastrointestinal 1CNS 1

Conditions

Anorexia 6Cachexia 5Weight Loss 3Breast Neoplasms 3Neoplasms 2Lung Neoplasms 2Body Weight 2Squamous Cell Carcinoma of Head and Neck 1Prosthesis Failure 1Pancreatic Neoplasms 1Nutrition Disorders 1Menorrhagia 1Liver Neoplasms 1Leiomyoma 1Hot Flashes 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Esthesioneuroblastoma, Olfactory 1Endometrial Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Body Weight Changes 1

Interventions

Megestrol Acetate 5anamorelin 1Standard of Care 1Radiotherapy 1Olanzapine 1Melatonin 1Infliximab 1Ibuprofen 1Etanercept 1Eicosapentaenoic Acid 1Docetaxel 1Dietary Supplements 1Cyproheptadine 1Creatine 1Counseling 1Caseins 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × Cachexia × Megestrol Acetate × Clear all
NCT00006799 2021-09-09

Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck Cancer

Wake Forest University Health Sciences

Phase 3 Completed
13 enrolled
CNSHead & Neck

Squamous Cell Carcinoma of Head and Neck, Anorexia, Cachexia, Head and Neck Neoplasms, Esthesioneuroblastoma, Olfactory

NCT00031785 2021-09-09

Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer

Wake Forest University Health Sciences

Phase 3 Completed
25 enrolled
Thoracic

Anorexia, Cachexia, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00031707 2016-07-14

Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite

Alliance for Clinical Trials in Oncology

Phase 3 Completed
429 enrolled

Anorexia, Cachexia

NCT00637728 2016-06-23

Treatment of Cancer-anorexia Using Megestrol Acetate Concentrated Suspension in Lung or Pancreatic Cancer Patients

Par Pharmaceutical, Inc.

Phase 3 Terminated
5 enrolled 8 charts
GastrointestinalThoracic

Anorexia, Body Weight, Cachexia, Lung Neoplasms, Pancreatic Neoplasms, Weight Loss

NCT00637806 2016-05-02

Treatment of Cancer-associated Anorexia Using Megestrol Acetate Concentrated Suspension

Par Pharmaceutical, Inc.

Phase 3 Terminated
4 enrolled 6 charts

Anorexia, Body Weight, Cachexia, Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡